Source link : https://www.newshealth.biz/health-news/fda-oks-first-rapid-acting-insulin-biosimilar-for-diabetes/
(MedPage Today) — The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference counterpart, insulin aspart (Novolog… Source link : https://www.medpagetoday.com/endocrinology/type1diabetes/114245 Author : Publish date : 2025-02-14 22:20:44 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-14 22:20:44
Copyright for syndicated content belongs to the linked Source.